Atlas Trials

Sertraline Versus Escitalopram in South Asian Participants With Moderate to Severe Major Depressive Disorder

Clinical trial NCT05950061 · COMPLETED

Trial details

NCT number
NCT05950061
Sponsor
KRL Hospital, Islamabad
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2022-06-01
Primary completion
2022-10-29
Enrollment
744

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.